Allergen rush immunotherapy increases interleukin (IL)-12 production and IL-12 receptor β2 chain expression in patients with allergic asthma

Interleukin (IL)-12 production and IL-12 receptor (IL-12R) β2 chain expression were investigated in patients with allergic asthma successfully treated with rush immunotherapy (RIT) and control patients with mild allergic asthma. Peripheral blood mononuclear cells (PBMCs) were stimulated with Dermatophagoides farinae (Der f), and production of cytokines was measured. Furthermore, the effects of cytokines on IL-12R β2 chain expression on CD4+ T cells were investigated. Production by PBMCs of IL-12 and IFN-γ was significantly higher and production of IL-4 was significantly lower after stimulation with Der f allergen in RIT-treated patients than in control patients. Significant increases in the expression of IL-12R β2 chain before and after stimulation of CD4+ T cells with IL-12 or IFN-γ were observed in RIT-treated patients compared with that in control patients. Allergen RIT increases IL-12 production and IL-12R β2 chain expression and thus may convert cytokine production from Th2 to Th1 or Th0 type in allergic asthma.